Open access

Early Diagnosis of Congenital Heart Disease in the Neonatal Period

Written By

Alfonso Ortigado

Submitted: October 28th, 2010 Published: August 17th, 2011

DOI: 10.5772/18611

Chapter metrics overview

4,635 Chapter Downloads

View Full Metrics

1. Introduction

Congenital heart disease (CHD) is present in 40-60% of children with Down syndrome (DS) and it is the principal variable that determines the morbimortality during the first two years of life of these patients.

Advances in fetal echocardiography are providing highly accurate diagnoses of congenital heart disease prior to delivery, making it possible to plan the delivery-room management of these newborns. However, the majority of neonates who have congenital heart disease will not require delivery room resuscitation in excess of routine care.

Although cardiovascular evaluation is a standard component of the diagnostic work-up in patients with Down syndrome, physical examination alone does not predict the presence or absence of congenital heart disease en the neonatl period. The changeover of fetal to neonatal circulation with the decrease in pulmonary vascular resistance (increase in pulmonary blood flow), the increase in systemic vascular resistance (the lower-resistance placenta is excluded from the circulation) and the timing of functional closure of the ductus arteriosus may determine the clinical presentation.

As physical examination alone is not sufficient to identify cardiovascular anomalies in neonates with Down syndrome and the early detection can improve the outcome of congenital heart defects, we need a newborn screening strategy, because failure to recognise these defects early in life can have serious consequences. Echocardiographic examination provides extensive anatomic and hemodynamic information noninvasively, in real time, and at relatively low cost. A routine echocardiography should be performed in this population in the neonatal period.

The aims of this chapter are:

  1. Congenital heart disease in Down syndrome.

  2. Normal and pathologic transitional circulation.

  3. Correlation between cardiac physical examination and echocardiography.

  4. Potential benefits of early diagnosis.


2. Congenital heart disease in Down syndrome

The association between DS and CHD has been well established since 1950, when the incidence and type of CHD present in newborns and infants with SD was thoroughly described (Evans, 1950)

In general population, CHD is one of the most common serious congenital anomalies, with an incidence about 1%occurring in up to 2% of liveborn children, and in an even higher percentage of fetuses. Children with DS have an increased incidence of CHD, 40%-60% is the range described in the world literature. The life expectancy of children with DS depends primarily on the risk of mortality in the first year of life and CHD is the major cause of mortality during the postneonatal period with 70% of cases (Weijerman et al, 2008)

Nevertheless, there are several factors that influence to determine the true incidence on CHD. Many forms of CHD are now detected by fetal echocardiography with early prenatal diagnosis of chromosomal abnormalities, and the parents may choose to abort these fetuses. Fetal echocardiography has shown that certain ventricular septal defects, may be detected in utero but have disappeared at the time of birth or within 6-12 months after. Studies using neonatal echocardiography have shown prevalence of muscular ventricular defect as high as 53 per 1000 live births, most babies were asymptomatic and most defects were small with early spontaneous closure rate of 89% within 1 to 10 months. These muscular ventricular defects may result from delayed physiologic development rather than from disease (Roguin et al, 1995). If they are not all included, this leads to the underestimation of the true incidence.

In general population, ventricular septal defects are the most common form of CHD, accounting for approximately 30%, but in DS patients, the endocardial cushion defect, also known as atrioventricular septal defects (AVSD), is the leading type, up to 40%(fig.1), followed in frecuency by ventricular septal defect (fig.2), atrial septal defect, patent ductus arteriosus and tetralogy of Fallot. Recent reports have shown that te distribution of congenital heart disease in children with DS may vary with ethnicity (De Rubens et al, 2003). Atrioventricular septal defects show the most significant sex and ethnic differences with twice as many affected females, and compared with whites, twice as many blacks, and half as many Hispanics (Freeman et al, 2008).

Figure 1.

Echocardiographic s apical four-chamber image demonstrating a complete atrioventricular septal defect (laminar flow without aliasing).

AVSD is caused by abnormal embryologic development of endocardial cushions and the bulboventricular fold. AVSD can be complete (common atrioventricular canal), partial (atrial septal defect of the ostium primum type or cleft anterior mitral leaflet) or intermediate form. Complete AVSD is characterized by the presence of a common atrioventricular orifice, an interatrial communication and a ventricular septal defect. In partial AVSD, also referred to as primum type atrial septal defect, the superior and inferior bridging leaflets arae connected bya a fibrous continuity in two functionally separate right and left atrioventricular orifices, and are firmly attached to the deficient septal crest, and the interventricualr communication is lacking. The intermediate form is defined as having a “scooped out“ interventricular septum with the atrioventricular valves being connected to the top of the septum by fibrous tissue “curtains“ and tendinous chordae, consequentelly resulting in a small or absent ventricular septal defect component (Hoohenkerk al, 2010).

Figure 2.

Echocardiographic apical four-chamber image demonstrating a ventricular septal defect (turbulent flow with aliasing).

Complete AVSD is associated with DS (60-86%) and clinically relevant differences have been identified in children with and without DS. Thus, left-side obstructions and right ventricular dominance, as well as left atrioventricular valve abnormalities such as double orifice valve and single papillary muscle, seem to be more prevalent in children with a normal chromosomal pattern, whereas Rastelli types B and C are more often found in patients with DS. Early progression of pulmonary vascular obstructive disease has been reported especially in patients with AVSD and DS (Lange et al, 2007).

AVSD can be complete (common atrioventricular canal), partial (atrial septal defect of the ostium primum type or cleft anterior mitral leaflet) or intermediate form, it can be isolated or combined with other cardiac anomalies, such as tetralogy of Fallot. Conversely, approximately 80% of all AVSD occur in children with DS.

Left-side obstructive defects such as coarctation of aorte and valvar aortic stenosis are rare, and transposition of the great arteries has not been reported in Down syndrome.

Many chromosomal syndromes are associated with a variety of CHD. Several of theses syndromes show a fixed pattern of CHD, such as 22q11-deletion syndrome, Noonan syndrome, Turner syndrome and Williams syndrome. Down syndrome also shows a fixed patern of CHD, with overrepresentation of septal defects and undrerepresentation of left-side obstructive defects and transposition of the great vessels. This observation, indicates that a locus on chromosome 21 is involved in the development of CHD. Althoug no single gene candidate has yet been identified to be responsible for this phenotype, genes for several matrix-related proteins (alfa-1 and alfa-2 type VI collagen, Down´s Syndrome Cell Adhesion Molecule, integrin beta-2 and alfa-1 XVIII collagen) are located on chromosome 21. Overexpression of type VI collagen has been suggested to play a role in the pathogenesis of atrioventricular septal defects in DS (Vis et al, 2009).


3. Normal and pathologic transitional circulation.

The pulmonary circulation undergoes a near-instantaneous change from its high resistance state in utero to a low resistance circuit after delivery to allow adequate pulmonary perfusion.

Delivery of the fetus from the uterus disrupts the umbilical-placental circulation and the functions of oxygen uptake and carbon dioxide removal are transferred to the lungs. The foramen ovale (fig.3) and the ductus arteriosus (fig.4) have to be closed functionally or anatomically to establish the adult circulation. Physical expansion of the lung, ventilation with oxygen and umbilical cord occlusion produce an increased in pulmonary blood flow and decrease in pulmonary vascular resistance. The pulmonary endothelium plays a crucial role in this adaption, the onset of breathing is associated with an increase in specific mediators such us nitric oxide and prostacyclin (pulmonary vasodilators and inhibitors of smooth muscle cell proliferation), and a decrease of vasoconstrictors (angiotensin and endothelin-1).

Figure 3.

Echocardiographic subcostal four-chamber image demonstrating a patent foramen ovale.

If pulmonary vascular resistance does not fall normally after birth, pulmonary arterial pressure will not drop to normal postnatal level, and pulmonary blood flow adequate for oxygen needs may not be established. This phenomenon has been named persistent pulmonary hypertension of the newborn (PPHN), and may result from several condition (perinatal asphyxia, meconium aspiration) (Suesaowalak et al, 2010).

A wide variety of cardiac disorders has been reported to cause PPHN and have been grouped into five types based on the physiology of the lesion (Long, 1990):

  1. Obstructions to pulmonary venous drainage (obstructed total anomalous pulmonary venous drainage, cor triatriatum, mitral stenosis...)

  2. Congenital cardiomyopathies (endocardial fibroelastosis, myocarditis...).

  3. Obstructions to left ventricular outflow (aortic atresia, critical aortic stenosis, interrupted aortic arch, coarctation...).

  4. Obligatory left-to-right shunts (cerebral arteriovenous malformations, hepatic arteriovenous malformations, complete atrioventricular septal defect...)

  5. miscellaneous cardiac disorders (Ebstein anomaly, tricuspid atresia, pulmonary atresia, transposition of the great vessels...)

Children with Down syndrome have an increased risk for developing pulmonary hypertension. The cause of pulmonary hypertension in this population is multifactorial and may be due to both anatomical and physiological alterations in the pulmonary circulation, including the presence of congenital heart disease with persistent left-to-right shunts, chronic upper airway obstruction, or abnormal pulmonary vasculature growth. Although damage to the pulmonary vasculature occurs over time, there also appears to be a subset of Down syndrome patients who develop pulmonary hypertension in the neonatal period. Neonatal DS patients have a greater incidence of persistent pulmonary hypertension of the newborn (PPHN) compared to the general population, and suggests that there may be something intrinsically related to DS that put these patients at increased risk for PPHN (Cua et al, 2007).

Figure 4.

Echocardiographic parasternal short-axis image demonstrating a patent ductus arteriosus (red flow at the ductus arteriosus and blue flow at both pulmonary arteries).


4. Correlation between cardiac physical examination and echocardiography

4.1. Clinical examination

Although CHD is present at birth, there are often no signs and most babies are asymptomatic. Skilled physical examination, a sensitive and specific screening tool in older children, does not always distinguish between neonates with or without CHD (Griebsch, 2007).

Wren et al. (1999) found no clinical signs in the first weeks in some children with DS, with major cardiac malformations and associated pulmonary hypertension, even in some who progressed to irreversible pulmonary vascular disease.

A normal neonatal examination in children with DS does not therefore exclude a serious CHD. Basic neonatal characteristics, Apgar scores, birth weight and gestational age are not different in children with DS with and without CHD (Weijerman et al, 2010).

The natural history of specific heart defects depends on the transitional circulation in the neonatal period, so the timing of the routine examination is very important. Heart murmurs have a prevalence of between 0.6% and 4.2% in newborns and are mistakenly considered a hallmark of heart disease (Patton, 2006). Transient murmurs due to tricuspid regurgitation (fig.5) and physiological peripheral pulmonic stenosis (fig.6) are the most common innocent murmurs in neonates (Du et al, 1997).

Figure 5.

Echocardiographic apical four-chamber image demonstrating a tricuspid regurgitation (blue jet from right ventricule to right atrium).

Practising pediatricians currently have limited experience in discriminating innocent from pathological murmurs. Detection of a murmur depends on the examiner´s skill and experience, the timing and the frequency of examination, and the conditions under which examination takes place.

Detection of a murmur on routine examination may be a clue to the presence of heart disease and offers the possibility of early, presymptomatic diagnosis. Early referral of all asymptomatic babies with murmurs is recommended for early definitive diagnosis by echocardiography. However, the absence of a murmur does not exclude the presence of potentially serious heart disease (Ainsworth et al, 1999).

Murmurs of atrioventricular septal defect and septal defect, the most common forms of CHD in SD, emerge after the decline in pulmonary resistance and may happen after neonatal discharge.

4.2. Electrocardiography

Electrocardiography (ECG) do not improve the sensitivity of the clinical assessment in the detection of CHD. Atrioventricular septal defects is associated with abnormal ECG (superior QRS axis), but most of the CHD have normal results on ECG (Mackie et al, 2009).

Sensivity and specific of a superior QRS axis to diagnose complete atrioventricular septal defect is 100% and 96.8%, respectively. However, the predictive value of neonatal ECG for other CHD is poor (Dennis et al, 2011).

Figure 6.

Echocardiographic parasternal short-axis image demonstrating a physiological peripheral pulmonic stenosis (yellow colour due to aliasing at the origin of both pulmonary arteries).

4.3. Chest radiography

There is no evidence that chest x ray (CXR) is a useful addition for neonatal diagnosis of CHD. CXR alone missed 39% of the cases of complete atrioventricular septal defect, whereas ECG missed only 17%. Combinig CXR, ECG and clinical examination gave little added benefit only 15% missed (Dennis et al, 2011).

In the evolution, but out of neonatal period, radiographic manifestations in infants with left-to-right shunts include cardiomegaly, prominence of the pulmonary vasculature, and dilatation of the central pulmonary arteries. With the severe and longstanding process, pulmonary artery hypertension appears, this shunt flow decreases and reverse, resulting in peripheral prunting of pulmonary vessels. As the pulmonary vascular resistance increases, if the congenital CHD is not corrected, the heart size may decrease (Suesaowalak et al, 2010).

4.4. Pulse oxymetry

Cyanosis in the newborn is difficult to detect at clinically important levels, murmurs may be missed or over diagnosed and femoral pulses are challenging to asses. Together with early discharge and failure to asses infants identified as at risk. The introduction of additional oxymetry screening could achieve better results at the relatively small cost. Pulse oximetry is a symple, non-invasive method of monitoring the pordentage of haemoglobin which is saturated with oxygen. The pulse oximeter consists of a probe attached to the infant´s finger, toe or edge of the foot, which is in turn linked to a computerised display of the porcentage of haemoglobin satured with oxigen and the heart rate. The examination can be performed by a junior doctor, midwife or other health professional. The equipment required is portable and ca be used in the home and hospital. An oximeter identifies hypoxemia and is dependent on a good peripheral circulation and so does not work reliably when a baby has a low blood pressure or is dehydrated, for example. Pulse oximetry may identify babies with cianotic CHD but not defects that only associated with murmurs or delay or absent pulses. Nevertheless, some authors thinks that pulse oximetry is a promising alternative newborn screening strategy (Knowles, 2005; Meberg, 2009), but others not (Reich, 2008. Sendelbach, 2008). Pulse oximetry cannot detect all cases of CHD, and parents should be informed, and hence, a negative test result does not exclude the possibility of heart disease. According to the American Heart Association and American Academy of Pediatrics, the usefulness of oximetry in clinical studies is not well stablished (Class IIb, Level of Evidence C), and future studies are needed to determine whether this practise should become standard of care in the routine assesment of the neonate (Mahle et al, 2009). Therefore, the screening with pulse oximetry should be carried out together with a clinical examination, never alone.

4.5. Echocardiography

Echocardiographic examination provides extensive anatomic and hemodynamic information noninvasively, in real time, and at relatively low cost. Echocardiographic windows are better in the newborn than at any other age because the lungs (impenetrable to ultrasound) do not get in the way as much, and the heart and great vessels are nearer the probe. The echocardiography must be a sistematic study with the standard views (left parasternal, apical, subcostal and suprasternal) and completed with Doppler ultrasound (colour Doppler, pulsed Doppler and continuous wave Doppler). Echocardiography is useful for initial evalution, cardiac defects, level of shunting, degree and directions of shunts, severety of pulmonary arterial hypertension, follow-up of the teatment and ventricular function can be delinaeted systematically. A routine echocardiography should be performed in this population in the neonatal period (AAP´s Committee on Genetics, 2001).

A patient is considered to have an abnormal cardiac physical examination if there is a cardiac murmur and/or cyanosis or an abnormal systemic arterial oxygen saturation, but a newborn without congenital heart disease but with persistent pulmonary hypertension of the newborn (PPHN) may present a cardiac murmur due to transient tricuspid insufficiency of cardiac dysfuntion, and cyanosis due to right-to-left shunting of blood across the patent ductus arteriosus and the foramen ovale. These clinical manifestations may alert the neonatologist and suspect the presence of a congenital heart diasease, but in deed, there is not.

The diagnosis can be confirmed by echocardiography with color Doppler imaging and documenting right-to lef shunting of blood through fetal circulatory pathways (ductus arteriosus and foramen ovale), in the abscence of CHD (fig 7, Fig 8). Contrast echocardiography is performed by rapidly injecting approximately 1ml of saline/blood mixture into a pheriperal vein while capturing a four-chamber view of the heart. The simultaneous appearance of bright echoes from cavitations in the fluid in the right ventricle and left atrium documents right-to-left atrial shunting. Because the right-to-left atrial shunt may be predominately of inferior vena cava, as it is in the normal fetal state, injection of fluid into a vein draining to the inferior vena cava may yield the best results (Fineman, Heymann & Morin, 2001).

Doppler echocardiography allows estimation of pulmonary artery systolic pressure. Because pulmonary artery and right ventricule systolic pressure are nearly equal in the absence of

Figure 7.

Echocardiographic parasternal short-axis image demonstrating a patent ductus arteriosus with right-to-left shunt (blue flow).

stenosis of right ventricule outflow tract, pulmonary artery systolic pressure is commonly estimated by techniques that measures right ventricule systolic prresure. In the method most commonly used, the tricuspid regurgitation jet is used to calculate the right ventricular-right atrial pressure gradient (Snider & Serwer, 1990).

Transthoracic echocardiograpy is useful for evaluation of severity of pulmonary arterial hypertension and ventricular function can be delineated systematically. The abnormal motion of the interventricualr septum and the eccentricity index estimate right ventricular pressure overload. The Tei index and the tricuspid annular plane systolic excursion (TAPSE) correlate with right ventricular function (Suesaowalak et al, 2010).

Figure 8.

Echocardiographic parasternal short-axis image demonstrating a patent ductus arteriosus with left-to-right shunt (orange flow).


5. Potencial benefits of early diagnosis.

Because of the high incidence of a significant CHD in children with DS, the early recognition of CHD can lead to the optimal management of the defect and emphasizes the importance of an early echocardiography of neonates with DS.

Early diagnosis of CHD in DS is important firstly because both the parents and the paediatrician need to know the implications of the heart defect. Secondly some major malformations with pulmonary hypertension may show no signs and may progress to irreversible pulmonary vascular disease before the heart defect has been recognised.

When fetal echocardiography was introduced into clinical practise, it become possible to study the spectrum of lesions associated with DS in prenatal life (fig.9) and the early diagnosis is of paramount importance (Paladini et al, 2000).

Figure 9.

Fetal echocardiography demonstrating a complete atrioventricular septal defect.

5.1. Pulmonary arterial hypertension

About half of all babies with DS will have CHD, and in around one-third of these this will comprise a complete atrioventricular septal defect with high risk of pulmonary vascular disease due to high pulmonary blood flow.

Among the numerous causes of pulmonary arterial hypertension, left-to-right shunt and chronic upper airway obstruction are frequently encountered in children with DS. Obstructive sleep apnoea is common in children with SD, affecting 30-50% of this patient group compared with 3% of the general paediatric population. This may result from a number of factors, including hypotonic upper airway, adeno-tonsillar hypertrophy, macroglossia, glossoptosis, flattened mid-face and narrow nasopharynx in these patients (Hawkins et al, 2011). This association of CHD in DS with pulmonary arterial hypertension, has led a neonatal screening and, as medical treatment becomes increasingly unsuccessful, early definitive cardiac surgery is usually undertaken at 3-6 months of age (Vohra et al, 2010). Many reports have demonstrated safe and effective repair in infants with atrioventricular septal defects within the first few months of live, and the presence of DS is not a risk factor (Lange et al, 2007).

In the past, infants with complete AVSD were initially palliated with pulmonary artery banding to prevent pulmonary vascular disease, followed by complete repair at a later stage to reduce mortality and morbidity. Better perioperative care and improvements in surgical and cardiopulmonary bypass techniques, allowed surgeons to successfully perform early repair. Nevertheless, there are situations in which early primary repair is not feasible or is accompanied by unacceptable risk. Reasons include unfavourable intracardiac anatomy (unbalanced ventricular morphology, associated lesions, or both), associated non cardiac malformation (exomphalos), or poor clinical condition (infection, chronic lung disease, renal or liver dysfunction, gastrointestinal or neurological complications). In these situations palliation with pulmonary artery banding followed by late repair is recognized as a viable surgical option (Dhannapuneni et al, 2011).

5.2. Nutrition

Failure to thrive is common in children with congenital heart disease. Infants with CHD are particularly at risk of energy imbalance that can involve deficiencies of specific nutrients, or insufficient total caloric intake. Malnutrition undermines the outcome of corrective surgical operations and postoperative recovery. Most infants with CHD have a normal weight for gestational age at birth but develop nutritional and growth problems in early infancy. Weight tends to be more effected than height; even so, almost half of infants younger than 2 years are stunted (Nydegger and Bines, 2006).

Mechanisms linking CHD to malnutrition may be related either to decreased energy intake and/or to increased energy requirements.

Decreased energy intake are in relation with anorexia and aerly satiety of these patients, decreased gastric volume caused by hepatomegaly, malabsorption due to edema and chronic hypoxia of the gut, pharmacologic agents, fluid restriction...

Increased in energy requirements can be due to increased respiratory rate accompanying congestive heart failure, cardiac hypertrophy, recurrent infections, increased activity of sympathetic nervous system, increased basal temperature...

The development of malnutrition depends on the type and severity of the cardiac lesion and associated disease condition. Infants with cyanotic heart lesions (tetralogy of Fallot) frequently have decreased weight and height compared with healthy infants. Chronic hypoxia is an important factor in anorexia and inefficient processing of nutrients at the cellular level. Atrioventricular septal defect and septal defect, the most common forms of CHD in DS, are acyanotic heart lesions but if there is a large left-to-right shunt, have reduced weight gain but growth may be maintained during infancy. However, in the presence of elevated pulmonary presure, severe growth failure frequently develops (Varan et al, 1999).

Associated genetic condition, Down syndrome, is another crucial factor and also influence energy intake, gastrointestinal absorption, expenditure, and growth expectations (Nydegger and Bines, 2006).

Most treatment strategies aim to facilitate "catch-up" growth, providing extra calories and protein that exceed the Recommended Dietary Allowance for age. However, there is no generally accepted set of guidelines that define appropriate caloric intake for catch-up growth. Early diagnosis of CHD in DS, brings out the nutrition challenge, the most effective nutrition strategies for children with CHD (Forchielly et al, 1994). Nutritional support via percutaneous endoscopic gastrostomy allows the safe delivery of the caloric intke needed in children with CHD and significant feeding-realed difficulties (Ciotti et al, 2002).

5.3. Prevention of infective endocarditis

It is recommended that parents and carers of all children with CHD should be given information about infective endocarditis preventive measures. Infective endocarditis is an uncommon but life-threatening infection. Despite advances in diagnosis, antimicrobial therapy, surgical techniques, and management of complications, patients with infective endocarditis still have high morbidity and mortality rates related to this condition.

The development of infective endocarditis is the net result of the complex interaction between the bloodstream pathogen with matrix molecules and platelets at sites of endocardial cell damage.

The American Heart Association (AHA) guidelines for infective endocarditis prophylaxis were published in 1997. The 1997 document stratified cardiac conditions into high-, moderate- and low-risk (negligible risk) categories, with prophylaxis not recommended for the low-risk group. Nevertheless, since this document, many medical societies and physicians have questioned the efficacy of the prophylaxis. The quality of evidence was limited to a few case-control studies or was based on expert opinion, clinical experience, and descriptive studies that utilized surrogate measures of risk.

“The Committee” of AHA extensively reviewed data and published the updated recommendations in October 2007. This new document is intended to identify which, if any, patients and procedures may possibly benefit from infective endocarditis prophylaxis, and result in greater clarity for patients, healthcare providers, and consulting professionals (Wilson et al, 2007).

5.4. Prevention of Respiratory Syncytial Virus infection

Children with DS have an increased incidence of respiratory tract infections which might be associated with CHD, abnormal airway anatomy and physiology, hypotonia, and aspiration. However, children with DS and without CHD, also have a high incidence of respiratory morbidity and might be explained by an aberrant immune system as well (Bloemers et al, 2010).

Respiratory syncytial virus (RSV) is an enveloped, nonsegmented, negative-strand RNA virus of the family Paramyxoviridae that causes respiratory tract infections in children. In the North- ern Hemisphere, the peak infection season is November through April. By two years of age, most children will have had an RSV infection. Bronchiolitis, a lower respiratory tract infection, is often caused by RSV. An RSV infection is diagnosed based on patient history and physical examination. RSV is recognized as the leading cause of hospitalization among young children worldwide. Infants of young chronologic age and children with predisposing factors, such as premature birth, pulmonary disease, or hemodynamically significant congenital heart disease, are most susceptible to serious illness. Children with DS have an increased risk of being hospitalized for RSV-induced lower respiratory tract infection, indicating DS as a risk factor (Bloemers et al, 2010). Unlike other viruses, immunity to RSV infection is incomplete and short lived, and reinfection is common throughout life. RSV infection remains difficult to treat, and prevention is a worldwide goal. Initial infection with RSV affords limited protection to reinfection, yet repeated episodes decrease the risk for lower respiratory tract illness. The development of palivizumab, a monoclonal antibody that can bind to a specific antigenic site on the virus and prevent cell-to-cell spread of infection has since become the mainstay of RSV illness prevention in preterm infants and those with significant congenital heart disease. Palivizumab, the only monoclonal antibody approved for the prevention of RSV lower respiratory tract disease must be administered monthly throughout the RSV season and does not always prevent serious RSV illness. Palivizumab is administered intramuscularly at a dose of 15 mg/kg once every 30 days, for a maximum of 5 doses. The American Academic of Pediatrics (AAP) published a policy statement on the use of palivizumab in November 1998, revised it in December 2003, and the last statement in the 2009 Red Book recommendations, safety and efficacy have been established for infants born at or before 35 weeks´ gestation with or without chronic lung disease of prematurity and for infants and children with hemodynamically significant heart disease (AAP, Committee on Infectious Diseases, 2009).


6. Conclusion

There is an increased incidence of congenital heart disease (CHD) and persistent pulmonary hypertension in Down syndrome (DS) neonates. A normal neonatal examination in children with DS does not therefore exclude a serious CHD. Clinical examination alone is insufficient to detect CHD in newborns. Failure to recognise these defects early in life can have serious consequences. The child´s future health, and indeed survival, may be severely compromised by late diagnosis. Neonatal echocardiography is the most effective single procedure and must be carried out by an appropiately trained person. A routine echocardiography should be performed in this population in the neonatal period.


  1. 1. AinsworthS. B.WyllieJ. P.WrenC.1999Prevalence and clinical significance of cardiac murmurs in neonates. Arch Dis Child Fetal Neonatal Ed. 80F43F45
  2. 2. American Academy of Pediatrics Committe on Genetics.2001Helth supervision for children with Down syndrome. Pediatrics. 107Nº.2, 4424491098-4275
  3. 3. BloemersB. L.van FurthA. M.WeijermanM. E.GemkeR. J.BroersC. J.KimpenJ. L.BontL.2010High incidence of recurrebt Wheeze in children with Down syndrome with and without previous Respiratory Syncitial Virus lower respiratory tract infection. Pediatr Infect Dis J. 2939420891-3668
  4. 4. BloemersB. L.BroersC. J.BontL.WiejermanM. E.GemkeR. J.van FurthA. M.2010Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes and Infection. 12799808
  5. 5. CiottiG.HolzerR.PozziM.DalzellM.2002Nutritional support via percutaneous endoscopic gastrostomy in children with cardiac disease experiencing difficulties with feeding. Cardiol Young. 12Nº.6, 537541
  6. 6. ClarkE. B.2001Etiology of congenital cardiovascular malformations : epidemiology and genetics, In : Moss and Adams´heart disease in infants, children and adolescents, including the fetus and young adult, Allen, HD. Gutgesell, HP. Clarck, EB. Driscoll, DJ. (Ed.), 6479Lippincot Williams & Wilkins, 0-68330-742-8USA.
  7. 7. Committee on Infectious diseases, American Academy of Pediatrics.2009Modified recommendations for use of Palivizumab for prevention of respiratory syncitial virus infections. Pediatrics. 124Nº.6, 16941702
  8. 8. CuaC. L.BlankenshipA.NorthA. L.HayesJ.NelinL. D.2007Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates. Pediatric Cardiology. 28250254
  9. 9. DhannapuneniR. R.GladmanG.KerrS.VenugopalP.AlphonsoN.CornoA. F.Complete atrioventricular septal defect: outcome of pulmonary artery banding improved by adjustable device. The Journal of Thoracic and Cardiovascular Surgery. 141179182
  10. 10. De RubensJ.Del PozzoB.BablosJ. L.CalderonC.CastrejonR.2003Heart malformations in children with Down syndrome. Rev Esp Cardiol. 56Nº.9, 894899
  11. 11. DennisJ.ArcherN.EllisJ.MarderL.2011Recognising heart disease in children with Down syndrome. Arch Dis Child Educ Pract, 9598104
  12. 12. DuZ. D.RoguinN.BarakM.1997Clinical and echocardiographic evaluation of neonates with heart murmurs. Acta Paediatr. 86752756
  13. 13. EvansP. R.1950Cardiac anomalies in mongolism. Br Heart J. 12258262
  14. 14. FinemanJ. R.HeymannM. A.MorinF. C.2001Fetal and postnatal circulations : pulmonary and persistent pulmonary hypertension of the newborn, In : Moss and Adams´heart disease in infants, children and adolescents, including the fetus and young adult, Allen, HD. Gutgesell, HP. Clarck, EB. Driscoll, DJ. (Ed.), 4163Lippincot Williams & Wilkins, 0-68330-742-8USA.
  15. 15. ForchielliM. L.Mc CollR.WalkerW. A.LoC.Children with congenital heart disease : a nutrition challenge. Nutr Rev. 52348353
  16. 16. FreemanS. B.BeanL. H.AllenE.TinkerS. W.LockeA. E.DruschelC.HobbsC. A.RomittiP. A.RoyleM. H.TorfsC. P.DooleyK. J.ShermanS. L.2008Ethnicity, sex, and the incidence of congenital heart defects : a report from the National Down Syndrome Projet. Genetics in Medicine. 10Nº.3, 173180
  17. 17. FudgeJ. C.LiS.JaggersJ.S. M.BrienE. D.PetersonJ. P.JacobsK. F.WelkeM. L.JacobsJ. S.LiS. K.Pasqualli2010Congenital heart surgery in Down syndrome : analysis of a national clinical database. Pediatrics. 12623153220031-4005
  18. 18. GriebschI.KnowlesR. L.BrownJ.BullC.WrenC.DezateuxC. A.2007Comparing the clinical and economic effects of clinical examination, pulse oximmetry, and echocardiography in newborn screening for congenital heart defects : a probabilistic cost-effectiveness model and value of information analysis. Int J Technol Assess Health Care. 23192204
  19. 19. HawkinsA.Langton-HewerS.HendersonJ.TullohR. M.2011Management of pulmonary hypertension in Down syndrome. Eur J Pediatr. Published online : 04 January. DOIs00431-010-1378-1
  20. 20. HoffmanJ.2009Epidemiology of congenital heart disease : etiology, pathogenesis, and incidence, In : Fetal cardiology. Embryology, genetics, physiology, echocardiographics evaluation, diagnosis and perinatal management of cardiac diseases, Yaguel, S. Silverman, N. Gembruch, U, (Ed), 101110Informa Healthcare, 978-0-41543-265-8New York, USA.
  21. 21. KhairyP.Ionescu-IttuR.MackieA. S.AbrahamowiczM.PiloteL.MarelliA. J.2010Changing mortality in congenital heart disease. Journal of the American College of Cardiology. 5614114911570735-1097
  22. 22. HoohenkerkG. J.BruggemansE. F.RijlaarsdamM.SchoofP. H.KoolbergenD. R.HazekampM. G.2010More than 30 years´experience with surgical correction of atrioventricular septal defects. Ann Thorac Surg. 9015541562
  23. 23. KnowlesR.GriebschI.DezateuxC.BrownJ.BullC.WrenC.2005Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health Technol Assess. 9(44), 1152iii-iv.
  24. 24. LangeR.GuentherT.BuschR.HessJ.SchreiberC.2007The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair. The Journal of Thoracic and Cardiovascular Surgery. 134304310
  25. 25. LongW.A. (1990). Persitent pulmonary hypertension of the newborn syndrome (PPHNS), In : Fetal & Neonatal Cardiology, Long, WA (Ed), pp. 627-655, Sounders Company, ISBN 0-7216-1887-1, Philadelphia, USA0-72161-887-1627655
  26. 26. MackieA. S.JutrasL. C.DanceaA. B.RohlicekC. V.PlattR.BelandM. J.2009Can cardiologists distinguish innocent murmurs from pathologic murmurs in neonates?. The Journal of Pediatrics. 1545054
  27. 27. MahleW. T.NewburgerJ. W.MathermeG. P.SmithF. C.HokeT. R.KoppelR.GiddingS. S.BeekmanR. H.GrosseS. D.2009Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement fron the American Heart Assiciation and American Academy Pediatrics. Circulation. 1204474580009-7322
  28. 28. MebergA.AndreassenA.BrunvandL.MarkestadT.MosterD.NietschL.SilbergI. E.SkalevikJ. E.2009Pulse oximetry screening as a complementary strategy to detect critical congenital heart defects. Acta Paediatrica. 98682686
  29. 29. NydeggerA.BinesJ. E.2006Energy metabolism in infants with congenital heart disease. Nutrition. 22697704
  30. 30. PaladiniD.TartaglioneA.AgangiA.TeodoroA.ForleoF.BorgheseA.MartinelliP.2000The association between congenital heart disease and Down syndrome in prenatal life. Ultrasound in Obstetrics and Gynecololy. 15104108
  31. 31. PattonC.HeyE.2006How effectively can clinical examination pick up congenital heart disease at birth?. Arch Dis Child Fetal Neonatal Ed. 91F263F267
  32. 32. ReichJ. D.ConnollyB.BradleyG.LittmanS.KoeppelW.LewyckyP.LiskeM.2008Reliability of a single pulse oximetry reading as a screening test for congenital heart disease in otherwise asymptomatic newborn infants: the importance of human factors. Pediatric Cardiology. 29371376
  33. 33. RoguinN.DuZ. D.BarakM.NasserN.HerschkowitzS.MilgramE.1995High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol. 2615451548
  34. 34. SendelbachD. M.JacksonG. L.LaiS. S.FixlerD. E.StehelE. K.EngleW. D.2008Pulse oximetryscreening at 4 hoursof age to detect critical congenital heart defects. Pediatrics. 122e815e820
  35. 35. SuesaowalakM.ClearyJ. P.ChangA. C.2010Advances in diagnosis and treatment of pulmonary arterial hypertension in neonates and children with congenital heart disease. World J Pediatr. 6Nº.1, 1331
  36. 36. VaranB.TokelK.YilmazG.1999Malnutrition and growth failure in cyanotic ans acyanotic heart disease with and without pulmonary hypertension. Arch Dis Child. 814952
  37. 37. VisJ. C.DuffelsM. G.WinterM. M.WeijermanM.CobbenJ. M.HuismanS. A.MulderB. J.2009Down syndrome: a cardiovascular perspective. Journal of Intellectual Disability Research. 53Nº5,419425
  38. 38. VohraH. A.ChiaA. X.YuenH. M.VettukattilJ. J.VeldtmanG.GnanapragasamJ.RomanH.SalmonA. P.HawM. P.Primary biventricular repair of atrioventricular septal defects: an analysis of reoperations. Ann Thorac Surg. 90830838
  39. 39. WeijermanM. E.van FurthA. M.NoordegraafA. V.van WouweP.BroersC. J.GemkeR. J.2008Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. The Journal of Pediatrics. 1521519
  40. 40. WeijermanM. E.van FurthA. M.van der MoorenD.van WeissenbruchM. M.RammelooL.BroersC. J.GemkeR. J.2010Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr, 16911951199
  41. 41. WilsonW.TaubertK. A.GewitzM.LockhartP. B.BaddourL. M.LevisonM.BolgerA.CabellC. H.TakahashiM.BaltimoreR. S.NewburgerJ. W.StromB. L.TaniL. Y.GerberM.BonowR. O.PallaschT.ShulmanS. T.RowleyA. H.BurnsJ. C.FerrieriP.GardnerT.GoffD.DurackD. T.2007Prevention of infective endocarditis : Guidelines from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery abd Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 116Nº9, 173617540009-7322
  42. 42. WrenG. L.RichmondS.DonaldsonL.1999Presentation of congenital heart disease in infancy : implications for routine examination. Arch Dis Child Fetal Neonatal Ed, 80F49F53

Written By

Alfonso Ortigado

Submitted: October 28th, 2010 Published: August 17th, 2011